Implementing the Breast Health Global Initiative guidelines
Prof Benjamin Anderson
12 Jul 2019
Guidelines for prepectoral implant-based breast reconstruction
Dr Raghavan Vidya - Royal Wolverhampton Hospital, Wolverhampton, UK
11 Jul 2019
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast ...
Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan
10 Jul 2019
Implementing national cancer control plans
Dr Eduardo Cazap and Dr Lisa Stevens
24 Jun 2019
PARP inhibitors olaparib and talazoparib as treatment for metastatic breast canc...
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
18 Jun 2019
The potential of PARP inhibitors in new cancer groups and in combination with ot...
Dr Jennifer Litton - The University of Texas MD Anderson Cancer Center, Houston,...
18 Jun 2019
BYLieve study results: Alpelisib and endocrine therapy in patients with PIK3CA-m...
Prof Hope Rugo - University of California, San Francisco, USA
12 Jun 2019
Advances in PARP inhibitor use for metastatic breast cancer
Prof Hope Rugo - University of California, San Francisco, USA
12 Jun 2019
Margetuximab for the treatment of HER2-positive breast cancer
Prof Debu Tripathy - The University of Texas MD Anderson Cancer Center, Houston,...
12 Jun 2019
DORA: Using olaparib alone or with durvalumab in platinum responsive advanced tr...
Dr Tira Tan - National Cancer Centre, Singapore
12 Jun 2019
EMBRACA: Results of talazoparib vs chemotherapy relative to prior CT in patients...
Dr Johannes Ettl - Technical University, Munich, Germany
12 Jun 2019
Ribociclib plus endocrine therapy improves survival in premenopausal patients wi...
Prof Debu Tripathy - The University of Texas MD Anderson Cancer Center, Houston,...
11 Jun 2019
